QING ZHANG

Associate Professor

University of Texas Southwestern Medical School

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Qing Zhang is an Associate Professor at the University of Texas Southwestern Medical School, USA. His research focuses on the molecular mechanisms underlying cancer, specifically in clear cell renal cell carcinoma and triple-negative breast cancer. Recent articles authored by Professor Zhang explore topics such as von Hippel–Lindau protein signalling, TBK1 activation in cancer cells, and the implications of α-ketoglutarate-dependent enzymes on therapeutic strategies.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Qin Yan

Yale University

UNITED STATES

View details

Rumela Chakrabarti

University of Pennsylvania

UNITED STATES

View details

Sanjeev Gumber

UNITED STATES

View details

Austin Hepperla

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Cheng Zhang

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

QING ZHANG

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma

Mechanism of TBK1 activation in cancer cells

α-Ketoglutarate-dependent Enzymes in Breast Cancer and Therapeutic Implications

Immature natural killer cells promote progression of triple-negative breast cancer

Optimized protocols for chromatin immunoprecipitation of exogenously expressed epitope-tagged proteins

Histone H3 proline 16 hydroxylation regulates mammalian gene expression.

An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.

HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans.

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer.

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway

TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling.

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer.

Collaborators (5)

Qin Yan

Rumela Chakrabarti

Sanjeev Gumber

Austin Hepperla

Cheng Zhang

Make your next move.